
The JPML issued a Transfer Order to centralize lawsuits alleging that manufacturers of diabetes and weight-loss drugs, like Ozempic, Wegovy, and Rybelsus, failed to adequately warn patients and doctors of the risk of dangerous gastrointestinal side effects. Cameron Stephenson, Attorney, Levin Papantonio Rafferty, is representing GLP-1RA claimants on behalf of the law firm. Plaintiffs are […]
The post JPML Centralizes Ozempic Gastroparesis Lawsuits first appeared on Beauty Ring Magazine.
